- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.08. | The Pulse of Innovation: How 3D Models Can Prepare Surgeons for the Operating Room | ||
| 21.08. | Modernizing Payment Integrity in an Era of Systemic Fraud | ||
| 21.08. | SCAN, Costco Launch Medicare Partnership | ||
| 20.08. | Ultragenyx Gene Therapy Becomes First FDA-Approved Treatment for Ultra-Rare Disease | ||
| 20.08. | The Imperative of Distinguishing Medical-Grade Devices from Wellness Tech | ||
| 20.08. | AI in Pharmacovigilance: Why Governance Will Define Success | ||
| 19.08. | Happy Health Snags $75M to Support Home-Based Care | ||
| 19.08. | Merck, Moderna Personalized mRNA Cancer Therapy Achieves a First for Melanoma | ||
| 19.08. | Why Bone Health Is Preventive Healthcare's Next Big Category | ||
| 19.08. | Included Health Taps Carrum Health for Value-Based Specialty Care | ||
| 18.08. | Amylyx Plans FDA Filing After GLP-1 Drug Hits Trial Goals in Rare Metabolic Condition | ||
| 18.08. | Rural US Healthcare Has A Cybersecurity Problem - CMS Funding Can Help Fix the Part No One Sees | ||
| 18.08. | KFF: Insurers Denied 12%-18% of Prior Authorization Requests in 2025 | ||
| 17.08. | Slate Medicines' Merger and $245M Private Placement Fuel Mission in Migraine | ||
| 17.08. | The Rise of Consumer Diagnostics and Emerging Trends | ||
| 17.08. | Healthcare Is Deploying AI Tools - It's Not Ready for AI Colleagues | ||
| 17.08. | How Payers and Health Plans Think of Identity and the Risks of Fragmented Data | ||
| 17.08. | The Reimbursement Challenges Hurting Women's Health Companies, Per Milken Institute | ||
| 17.08. | Vogenx IPO Raises $81M for Trial in Metabolic Disease With No Approved Drugs | ||
| 16.08. | Better Models Won't Fix Pharma's AI Problem - Better Terminology Will | ||
| 16.08. | The True Cost of Focusing on Cost Instead of Cost-Effectiveness | ||
| 14.08. | Patient Group Sues AMA, Says the Org Shouldn't Be Charging for CPT Codes | ||
| 14.08. | Aligned Marketplace Secures $20M for Advanced Primary Care Marketplace | ||
| 14.08. | Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma | ||
| 14.08. | Healthcare Keeps Buying AI. But Nobody's Building the Workforce to Run It. |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.